Journal Review 2024: Appropriate Use Criteria - Estrogen Receptor Imaging
Tracking # 20-1269200
$99999.00
There are no ratings for this course
Learn moreCourse overview
UAN: 0018-0000-24-223-H01-P & T RELEASE: 12/01/2024 EXPIRE: 12/01/2025 CREDITS: 1.5 LEARNING OBJECTIVES: 1. Understand the role of estrogen receptor imaging in patients with breast cancer 2. Review the most common indications for the use of F-18 fluoroestradiol imaging 3. Recognize the most common disease scenarios and how F-18 fluoroestradiol fits into patient evaluation NOTE: An annual subscription for Purdue's nuclear pharmacy re-certification program provides access to both the continuing education component of the program and the "Radiopharmacy Portal" a reference resource for practitioners. Subscriptions to the continuing educational offerings, which have been accredited through ACPE and BPS, can be purchased for an annual fee of $225 for nuclear pharmacists and $125 for nuclear pharmacy technicians.
Subject areas
This course counts toward the state boards and subject areas below.